Close Menu

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis reported today that its total revenues for the first half of 2017 fell 3 percent year over year, as higher product sales were offset by a drop in collaboration revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.